[{"Assets_0_Q3_USD":301377000.0,"CommonStockSharesOutstanding_0_Q3_shares":562119334.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-32959000.0,"NetIncomeLoss_1_Q3_USD":-878000.0,"NetIncomeLoss_3_Q3_USD":-42875000.0,"StockholdersEquity_0_Q3_USD":228985000.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]